Aspirin

As per available reports about 17 journals, 5 Conferences, workshops are presently dedicated exclusively to aspirin and about 22927 articles are being published on the current trends in aspirin. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to proteomics are being carried out. As reported in the above mentioned 354828 articles, Aspirin, also known as acetylsalicylic acid, is a salicylate drug, often used as an analgesic to relieve minor aches and pains, as an antipyretic to reduce fever, and as an anti-inflammatory medication. Aspirin also has an antiplatelet effect by inhibiting the production of thromboxane, which under normal circumstances binds platelet molecules together to create a patch over damaged walls of blood vessels.

Pharmaceutical Analytica Acta is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals in Aspirin. Each year research scientists have noticed a rise in the number of congresses being held in this field. The Pharmaceutical Analytica Acta provides a unique platform to researchers and scientist to explore the advanced and latest research developments in the field of aspirin, thus bridging the gap between researchers and young scientists.

OMICS International – a pioneer in organizing international conferences is about to conduct a conference on Aspirin medicine. OMICS Group organizes over 100 Scientific Conferences all over the globe annually with the support from various scientific associations and 20,000 editorial board members. Since its inception, OMICS Group has focused on meeting the needs of the scientific community, through strong tie-up with business and industry, while at the same time accomplishing international benchmarks and accreditation standards.